HS code · 4-digit heading
HS Code 30.01 – Glands and other organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.c.
What HS 30.01 covers
Heading 3001 covers "Glands and other organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.c." This heading is crucial for biological raw materials used in the pharmaceutical industry. It encompasses substances derived directly from human or animal glands and organs, specifically when intended for therapeutic applications that leverage their physiological properties. A key inclusion is heparin and its salts, a vital anticoagulant, regardless of its source. The scope is defined by the origin (glands/organs) and the intended 'organo-therapeutic' use, distinguishing it from blood products (3002) or other medicinal preparations. Key sub-categories include various glandular extracts (e.g., thyroid, adrenal, pancreatic) and specific therapeutic enzymes like pepsin or trypsin, provided they are for therapeutic or prophylactic uses. This classification is vital for trade compliance due to the biological nature and regulatory scrutiny of these products. Accurate classification ensures adherence to health regulations, veterinary controls, and proper customs procedures. Historically, organotherapy has been practiced for centuries, evolving into modern pharmaceutical extraction and purification techniques. This heading forms an essential part of Chapter 30, which focuses on pharmaceutical products, placing these biological raw materials at the beginning of the pharmaceutical supply chain within Section VI.
- Covers
- Heparin sodium
- Heparin calcium
- Pancreatic enzyme extracts
- Thyroid gland extract
- Adrenal gland extract
- Pituitary gland extract
- Ovarian extract
- Testicular extract
- Liver extract
- Brain extract
- Placental extract
- Pepsin (for therapeutic use)
- Trypsin (for therapeutic use)
- Chymotrypsin (for therapeutic use)
- Hyaluronidase (for therapeutic use)
- Collagenase (for therapeutic use)
- Elastase (for therapeutic use)
- Thrombin (for therapeutic use)
- Fibrinogen (for therapeutic use)
- Gastric mucin (for therapeutic use)
- Bile extracts
- Spleen extracts
- Thymus extracts
- Bone marrow extracts
- Cartilage extracts
- Examples
A pharmaceutical company in Germany imports bulk Heparin sodium, derived from porcine intestines, from China for the manufacture of injectable anticoagulants. Separately, a US-based firm specializing in digestive health products ships purified pancreatic enzyme extracts from bovine sources to Japan, where they are formulated into capsules for treating exocrine pancreatic insufficiency. Furthermore, a biotech firm in Denmark exports highly purified collagenase, extracted from animal tissues, to a hospital supply company in Brazil for use in advanced wound care and debridement applications.
Subheadings under 30.01 2
Codes often confused with 30.01
Common mistake. Common misclassifications include confusing 3001 with 3002 (human blood, animal blood, immunological products) or 3507 (enzymes; prepared enzymes not elsewhere specified or included). The key distinction for 3001 is its origin from *glands or other organs* (not blood) and its explicit *organo-therapeutic* or *therapeutic/prophylactic* use, or specifically heparin. Enzymes for industrial or diagnostic (non-therapeutic) use would typically fall under 3507 or 3822 respectively. Products that are highly processed and chemically defined might also be mistaken for Chapter 29 chemicals.
Top exporters and importers of HS code 3001, 2025
In 2025, the largest exporter of HS code 3001 in UN Comtrade data was the United States, with 20% of world exports; the largest importer in UN Comtrade data was the United States, with 15% of world imports. Countries that did not report 2025 data are estimated from partner records, which can understate them.
Top exporters 2025 · share of world exports
- 1 United States $663M 20% of world exports
- 2 China $605M 19% of world exports
- 3 Singapore $338M 10% of world exports
World total: $3.3B Reported figures on UN Comtrade ↗
Top importers 2025 · share of world imports
- 1 United States $470M 15% of world imports
- 2 France $360M 12% of world imports
- 3 Singapore $236M 7.7% of world imports
World total: $3.1B Reported figures on UN Comtrade ↗
How these figures are built
109 countries reported 2025 trade to UN Comtrade in HS 2022, and their own totals are used. Countries that did not report are estimated from what other countries recorded trading with them. Those estimates miss trade with other non-reporting countries, so they can be low, and a non-reporting country can rank higher than shown or be missing from the list. World totals add both and leave out trade between two non-reporting countries. Figures are in current US dollars; reported imports are mostly valued CIF and exports FOB, and exports include re-exports. The UN Comtrade links show the underlying records; they can also list a few reporters left out here (regional groups and older HS editions).
Source: UN Comtrade (United Nations Statistics Division), 2025 annual data.
Questions about HS 30.01
What is HS code 3001?
HS code 3001 is a 4-digit heading in the Harmonized System that covers: Glands and other organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.c.. Heading 3001 covers "Glands and other organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.c." This heading is crucial for biological raw materials used in the pharmaceutical industry. It encompasses substances derived directly from human or animal glands and organs, specifically when intended for therapeutic applications that leverage their physiological properties. A key inclusion is heparin and its salts, a vital anticoagulant, regardless of its source. The scope is defined by the origin (glands/organs) and the intended 'organo-therapeutic' use, distinguishing it from blood products (3002) or other medicinal preparations. Key sub-categories include various glandular extracts (e.g., thyroid, adrenal, pancreatic) and specific therapeutic enzymes like pepsin or trypsin, provided they are for therapeutic or prophylactic uses. This classification is vital for trade compliance due to the biological nature and regulatory scrutiny of these products. Accurate classification ensures adherence to health regulations, veterinary controls, and proper customs procedures. Historically, organotherapy has been practiced for centuries, evolving into modern pharmaceutical extraction and purification techniques. This heading forms an essential part of Chapter 30, which focuses on pharmaceutical products, placing these biological raw materials at the beginning of the pharmaceutical supply chain within Section VI.
What products fall under HS code 3001?
Heparin sodium, Heparin calcium, Pancreatic enzyme extracts, Thyroid gland extract, Adrenal gland extract, Pituitary gland extract, Ovarian extract, Testicular extract, Liver extract, Brain extract, Placental extract, Pepsin (for therapeutic use), Trypsin (for therapeutic use), Chymotrypsin (for therapeutic use), Hyaluronidase (for therapeutic use), Collagenase (for therapeutic use), Elastase (for therapeutic use), Thrombin (for therapeutic use), Fibrinogen (for therapeutic use), Gastric mucin (for therapeutic use), Bile extracts, Spleen extracts, Thymus extracts, Bone marrow extracts, Cartilage extracts
What are common misclassifications for HS code 3001?
Common misclassifications include confusing 3001 with 3002 (human blood, animal blood, immunological products) or 3507 (enzymes; prepared enzymes not elsewhere specified or included). The key distinction for 3001 is its origin from *glands or other organs* (not blood) and its explicit *organo-therapeutic* or *therapeutic/prophylactic* use, or specifically heparin. Enzymes for industrial or diagnostic (non-therapeutic) use would typically fall under 3507 or 3822 respectively. Products that are highly processed and chemically defined might also be mistaken for Chapter 29 chemicals.
Which countries are the top exporters of goods under HS code 3001?
In 2025, the top exporters of HS code 3001 in UN Comtrade data were the United States ($663M, 20% of world exports), China ($605M) and Singapore ($338M). World exports came to about $3.3B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
Which countries are the top importers of goods under HS code 3001?
In 2025, the top importers of HS code 3001 in UN Comtrade data were the United States ($470M, 15% of world imports), France ($360M) and Singapore ($236M). World imports came to about $3.1B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
How is HS code 3001 structured?
HS code 3001 is a 4-digit heading under Chapter 30 of the Harmonized System. The first 2 digits (30) identify the chapter, and digits 3-4 (01) specify the heading. This code contains multiple 6-digit subheadings for precise product classification.